Sign up for free shipping on all website orders, no minimum required, and get exclusive coupons!
Users can now ask questions to the AI chatbot by clicking the chatbot icon in the bottom-right corner of the website.
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 91832-40-5 | Product Number: C3111
Cefdinir
×
Purity: >97.0%(T)(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 1G |
$105.00
|
Ships from Portland the same day* | 1 | 11 |
|
|
| 5G |
$263.00
|
2 | 1 | 1 |
|
* Items in stock locally typically ship the same day of ordering. Items from Japan stock are able to ship from a US warehouse within 2 weeks after ordering. For additional estimated shipment times, please refer to the Shipping Simulation tool. Note: Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C3111 |
Purity / Analysis Method 
|
>97.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__4H__1__3N__5O__5S__2 = 395.41 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 91832-40-5 |
| Reaxys Registry Number | 6829362 |
| PubChem Substance ID | 253660757 |
| Merck Index (14) | 1920 |
| MDL Number | MFCD00865030 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
| Specific rotation [a]20/D | -58.0 to -66.0 deg(C=1,0.1mol/L buffer sol. pH7.0 Phosphate) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 190 °C(dec.) |
| Specific Rotation | -65° (C=1,0.1mol/L pH7.0 phoshate Buffer) |
| Maximum Absorption Wavelength | 295 nm (DMSO) |
| Solubility in water | Insoluble |
| Solubility (insoluble in) | Ether, Ethanol |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust. P285 : In case of inadequate ventilation wear respiratory protection. P280 : Wear protective gloves. P272 : Contaminated work clothing must not be allowed out of the workplace. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P363 : Wash contaminated clothing before reuse. P304 + P341: IF INHALED: If breathing is difficult, remove person to fresh air and keep comfortable for breathing. |
Related Laws:
| RTECS# | XI0367250 |
Transport Information:
| HS Number | 2941.90.5000 |
Application
Cefdinir: A Third-Generation Cephalosporin More Active Against Gram-Positive Organisms
Cefdinir (FK482) is an oral third-generation cephalosporin with vinyl group at the 3-potition and 2-aminothiazolylhydroxyimino group at the 7-potition of 7-ACA [A1266]. Cefdinir has a broad spectrum of activity against many Gram-negative and Gram-positive organisms, but does not have activity against Pseudomonas aeruginosa. Cefdinir is more active than other cephalosporins (e.g. cephalexin [C2248]) against Gram-positive organisms such as Staphylococcus aureus and strains of the Streptococcus group. Cefdinir is stable to hydrolysis by β-lactamases. (The product is for research purpose only.)
References
- In vitro antibacterial activity of FK482, a new orally active cephalosporin
- Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin (a review)
- Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections (a review)
- Method development for the determination of cefdinir and its related substances by high-performance liquid chromatography
- Polymorphisms and Patent, Market, and Legal Battles: Cefdinir Case Study
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Enter TCI Product Number
Enter KISHIDA Product Number
4-5 alphanumeric characters before the hyphen
7 alphanumeric characters
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
• The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
• Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
• If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
• Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
The requested analytical chart is not available. Sorry for the inconvenience.